Chip ETF Rebound Masks a Brutal Month as Ballot-Box Fears Reshape the AI Trade
Redcare Pharmacy Crosses 15 Million Active Customers as Analysts Split on Price Targets
Bayer Balances a Wider Loss Against a Brighter Outlook and a Chinese First
Barrick's November 9 Reckoning: Can a Gold Tailwind Survive Contact With the P&L?
PepsiCo Bets on Holiday Shelf Space and KFC's Youth Appeal While North America Still Drags
Rheinmetall's €78 Billion Question: Can Europe's Defense Champion Convert Orders Into Revenue?
Siemens Trades Sideways as Analysts Weigh Electrification Strength Against Automation Doubts
UBS's Capital Bill Hangs on a November Vote as Cyber Risk Enters the Frame
Volkswagen Loosens Its Zero-Wage Playbook as a 1% Margin Leaves Little Room for Error
Tesla's Robot Rental Bet Meets a Wall Street Bounce
Lufthansa Clinches TAP Stake as Bernstein Flags Revenue Test for Full-Year Target
Deutsche Telekom Balances Raised Guidance With a Bigger Payout and Fresh AI Ambitions
DZ Bank Turns Bearish on Apple as New Macs Hit Shelves and a $7.5 Billion Bond Lands
OHB's November Reckoning: Can Technical Wins Translate Into Earnings?
BASF's Buyback and Upgraded Guidance Take Centre Stage Ahead of November 23 Capital Markets Day
Voestalpine Traders Weigh Deutsche Bank's EUR 63 Target Against a Softer Quarter
Palantir's Partner Wins Give the Growth Story a Factory Floor
Petrobras Plans November Diesel Imports as Refineries Run Near Capacity
Newmont's Buy Case Meets Its Toughest Test: A Cost Curve That Climbs Into 2027
Bajaj Mobility's Quarterly Profit Faces a Nine-Month Reality Check
Thyssenkrupp's Duisburg Green-Steel Plant Pushed to 2029, With Hydrogen Supply the Real Test
Copper Miners ETF Whipsawed as Political Risk Collides With Tight Supply
Daimler Truck's North American Surge Lifts Quarterly Profit 73% as Order Gap Clouds Outlook
Leonardo's €60 Billion Backlog Faces a Two-Pronged Execution Test
Bechtle's Profit Growth Lags Revenue as Analysts Split on the Upside
Nvidia's $3 Billion Bet on Meta Comes With a Washington Asterisk
Uniper Courts Buyers With 7% Dividend Growth Pledge as Equinor Weighs Joining Brookfield Bid
Coeur Mining's Rainy River Accounting Drag Masks a Quarter of Real Cash Generation
BAT Draws Goldman Upgrade and FDA Clearance for Velo as Capital Group Slips Below 18% Stake
Erste Group Wins Private Banking Plaudits as Analysts Split on Valuation After Upgraded Outlook
BAT's C$187.5 Million Organigram Bet Lands Alongside FDA Nod for Velo and a Goldman Upgrade
Torm Locks In 53% of Fourth-Quarter Earning Days as Dividend and Newbuilds Share the Capital Bill